Serious Recall Issued for Bravo Capsule Devices Over Attachment Failures
Healthcare Purchasing News · September 16, 2026
The FDA has issued a Class I recall for Bravo CF esophageal pH-monitoring capsules due to attachment failures. This recall represents a critical safety issue for a medical device used in diagnostic procedures.
Read the full article on Healthcare Purchasing News